02/08/2010. 1. Background. Outline

Similar documents
Identification of T-cell epitopes of SARS-coronavirus for development of peptide-based vaccines and cellular immunity assessment methods

Title: Mapping T cell epitopes in PCV2 capsid protein - NPB # Date Submitted:

The role of IBV proteins in protection: cellular immune responses. COST meeting WG2 + WG3 Budapest, Hungary, 2015

Detection of T-cell T and their application to vaccine design

Swine Health. Beth Ferry MSU Extension Pork Educator

specific B cells Humoral immunity lymphocytes antibodies B cells bone marrow Cell-mediated immunity: T cells antibodies proteins

Analysis of the adaptive immune response to West Nile virus

The public health risk of influenza in pigs recent insights, key knowledge gaps

Overview of the Cattle Immune System 1

WHO Regional Office for Europe update on avian influenza A (H7N9) virus

Modelling and analysis of T-cell epitope screening data.

Identification of Tick-Borne Encephalitis Virus CD4+ and CD8+ T-Cell Epitopes in Vaccinated or Naturally Infected Humans

CONTENT. Chapter 1 Review of Literature. List of figures. List of tables

Why study T cell epitopes in allergic disease?

Chapter 43: The Immune System

Natalia Taborda Vanegas. Doc. Sci. Student Immunovirology Group Universidad de Antioquia

Core Topic 2. The immune system and how vaccines work

Immune Epitope Database NEWSLETTER Volume 7, Issue 1 March 2010

EFFECT OF PREDATED VACCINATION AND CHINESE HERBAL ADJUVANT RABBIT HEMORRHAGIC DISEASE VACCINE ON IMMUNE RESPONSE IN YOUNG RABBITS

excerpted from Reducing Pandemic Risk, Promoting Global Health For the full report go to

4

Diagnostic Testing and Strategies for BVDV

Immunity Unit Test Z

Figure 4.1: Gel picture showing Generation of HIV-1subtype C codon optimized env expressing recombinant plasmid pvax-1:

Changing Concept of FMD diagnostics: from Central to Local. Aniket Sanyal Project Directorate on FMD Mukteswar, India

Why use passive immunity?

Understanding West Nile Virus Infection

Downloaded from:

The Body s Defenses CHAPTER 24

How To Understand The State Of The Art In Animal Health Risk Assessment

JIANGSU CARTMAY INDUSTRIAL CO.,LTD mail:

Keeping Show Pigs Healthy

Hapten - a small molecule that is antigenic but not (by itself) immunogenic.

Prospects for Vaccines against Hepatitis C Viruses. T. Jake Liang. M.D. Liver Diseases Branch NIDDK, NIH, HHS

Name (print) Name (signature) Period. (Total 30 points)

Application of Neutralization Fingerprinting in Antibody Epitope Prediction and Delineating Antibody Recognition in HIV-1 Sera

Guidelines for TB Blood Testing. Minnesota Department of Health TB Prevention and Control Program June 2011

Improves pig performance in a wide range of health and growing conditions

The Functional but not Nonfunctional LILRA3 Contributes to Sex Bias in Susceptibility and Severity of ACPA-Positive Rheumatoid Arthritis

Madolyn Drebenstedt Mediapolis High School Mediapolis, IA Philippines, Factor 4 Animal Health Philippines: Porcine Epidemic Diarrhea Virus In the

Lisa Y. Armitige, MD, PhD has the following disclosures to make:

AgFeed Industries, Inc

Pandemic Influenza Vaccines: Lessons Learned from the H1N1 Influenza Pandemic

CHAPTER 8 IMMUNOLOGICAL IMPLICATIONS OF PEPTIDE CARBOHYDRATE MIMICRY

Chapter 18: Applications of Immunology

PperCHIP. High-Content Peptide Microarrays. Epitope Mapping & Serum Profiling Services

Immunity and how vaccines work

SYMPOSIUM. June 15, Photonics Center Colloquium Room (906) 8 Saint Mary's St., Boston, MA Boston University

WHY IS THIS IMPORTANT?

Canine Influenza. What do I need to know?

Mouse IFN-gamma ELISpot Kit

TOWARDS AN HIV VACCINE

Recognition of T cell epitopes (Abbas Chapter 6)

Preventing CSF re-emergence: a continuous challenge

Immunology Ambassador Guide (updated 2014)

Microbiology AN INTRODUCTION EIGHTH EDITION

Swine Influenza Special Edition Newsletter

T cell Epitope Prediction

Antibody responses to linear and conformational epitopes

Gene Therapy. The use of DNA as a drug. Edited by Gavin Brooks. BPharm, PhD, MRPharmS (PP) Pharmaceutical Press

Production of antigens and antibodies in plants: alternative technology?

The Immune System and Disease

Cytomegalovirus (HHV5/CMV) Roseolovirus (HHV6 & 7)

IKDT Laboratory. IKDT as Service Lab (CRO) for Molecular Diagnostics

BE SURE. BE SAFE. VACCINATE.

2) Macrophages function to engulf and present antigen to other immune cells.

SUMMARY AND CONCLUSIONS

T Cell Maturation,Activation and Differentiation

Network Intrusion Detection System and Its Cognitive Ability based on Artificial Immune Model WangLinjing1, ZhangHan2

QUALITY MANAGEMENT IN VETERINARY TESTING LABORATORIES

Focus on Preventing Disease. keeping an eye on a healthy bottom line. Cattle Industry

Influenza and Pandemic Flu Guidelines

HuCAL Custom Monoclonal Antibodies

Vaccination Programs for the Cow/Calf Operation

1) Siderophores are bacterial proteins that compete with animal A) Antibodies. B) Red blood cells. C) Transferrin. D) White blood cells. E) Receptors.

Biopharmaceutical Process Evaluated for Viral Clearance

Don t gamble on your HERD S health.

DNA Vaccine for Chronic Hepatitis C

Chapter 16: Innate Immunity

ELISA BIO 110 Lab 1. Immunity and Disease

Rheumatoid arthritis: an overview. Christine Pham MD

LESSON 3: ANTIBODIES/BCR/B-CELL RESPONSES

International Symposium on Malignant Mesothelioma curemeso.org

Principles of Disease and Epidemiology. Copyright 2010 Pearson Education, Inc.

FACULTY OF MEDICAL SCIENCE

10. T and B cells are types of a. endocrine cells. c. lymphocytes. b. platelets. d. complement cells.

7- Master s Degree in Public Health and Public Health Sciences (Majoring Microbiology)

Tuberculosis and HIV/AIDS Co-Infection: Epidemiology and Public Health Challenges

PHYLOGENY AND EVOLUTION OF NEWCASTLE DISEASE VIRUS GENOTYPES

CHAPTER 2 ANTIGEN/ANTIBODY INTERACTIONS

Identification of CD4+ T cell epitopes specific for the breast cancer associated antigen NY-BR-1

Making the switch to a safer CAR-T cell therapy

QuantiFERON TB Gold In Tube Method (QGIT Test) Manufacturer: Cellestis Inc. (USA) a QIAGEN Company

MOLECULAR BIOLOGY 4P03 / BIOLOGY 6P03 - Medical Microbiology

If you have a cold or the flu, you can spread the sickness to someone else. How does the sickness spread? Write your ideas on the lines below.

Custom Polyclonal Anti-Peptide Antibody, Brochure

Course Curriculum for Master Degree in Veterinary Epidemiology/Faculty of Veterinary Medicine

Mapping the T-Cell Epitope of the Paraflagellar Rod Protein 3 of Parasitic Hemoflagellate, Trypanosoma Cruzi

Course Curriculum for Master Degree in Food Hygiene /Faculty of Veterinary Medicine

MARSHALL UNIVERSITY BOARD OF GOVERNORS Policy No. AA-4 MEASLES AND RUBELLA IMMUNIZATION POLICY

Transcription:

Identification of immunodominant T-cell eptitopes in matrix protein of highly pathogenic porcine reproductive and respiratory syndrome virus Ya-Xin Wang, PhD Student Outline 1. Background 2. Research Contents 3. Conclusion 4. Acknowledgement Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences Introduction of HP-PRRSV 1. Background In 2006, Highly pathogenic porcine reproductive and respiratory syndrome virus(hp-prrsv) severely affected the pork industry of China. Infections were characterized by high morbidity (characterized by high fever, 50-100%) and mortality (20-100%). Since the initial outbreak, disease spread rapidly to most provinces in China, resulting in more than one million deaths. So we chose the HP-PRRSV HuN4 strain to do the research. 1985 1987 1990 1991 1992 1995 2000 2005 2006 2010 First observed in The United States The first case reported in Europe First isolated in Lelystad Isolated in Lelystad The United States Officially named PRRSV First outbreak on mainland China Highly pathogenic PRRS The course of viral infections in pigs PRRS Immunology Persistent Infection Delayed Protection! Persistent Infection! 1

Pig immune to PRRSV is not very effective Innate Immunity Cytokines Interferons: IFN-α, IFN- β Ribonuclease Other Cytokines: IL-1/TNF NSP2 antagonizes the type I IFN TC Cell CMI IL-2 IL-12, IFN-g Intracellular CTL Th1 Cell Kill Infected Cells IL-2 Delayed IFN-γ secreting cells PRRSV Adaptive Immunity TH Cell Humoral Immunity Th2 Cell Extracellular Absorb Free Virus B Cell Neutralizing Antibody Delayed Neutralizing Antibody B cell epitopes of ATCC VR-2332 strain 112-123aa 839-849aa 1032-1067aa 691-722aa 236-252aa 30-52aa 180-197aa 36-51aa21-47aa 5'cap 1a 2a 4 6 1b 2b 3 5 7 (A)n 3' 456-469aa 117-139aa 752-807aa 1750-1755aa 913-940aa 90-148aa 27-35aa,37-45aa B cell epitopes of CH-1a strain 119-178aa 146-156aa 164-180aa,182-200aa 69-122aa 37-52aa 51-56aa 117-129aa 52-58aa 54-58aa T cell epitopes 175-183aa Ivan Díaza et al. Lelystad virus strain 7-15aa 113-121aa 64-72aa 117-128aa 5'cap 1a 2a 4 6 1b 7 (A)n 3' 2b 3 5 2. Research Contents Vashisht K, et al. NADC-9, NVS-14 virus strain 149-163aa 187-200aa Experimental design PRRS-negative piglets First vaccinated, then challenged with HP-PRRSV PBMCs ELISPOT Further proven experiment Conservation of identified M epitopes Matrix protein of PRRSV Fifteen amino acid residues in length, overlapped by 11 residues Overlapping Peptides The ELISPOT screening Peptides spanning matrix protein were screened for their ability to elicit a recall interferon-γ (IFN-γ). All of the peptides Three rounds, step by step, reduce the scope Individual peptide epitopes 2

First distribution of Peptide pools Second distribution of Peptide pools I2 II2 III2 Pool VI1 Group 6 M26-M29 Group 1 M1-M5 Pool I1 Group 2 M6-M10 IV2 V2 VI2 VII2 M1 M4 M7 M10 M2 M5 M8 M11 M3 M6 M9 M12 Pool V1 28 peptides Pool II1 VIII2 M13 M14 M15 Group 5 M21-M25 Group 3 M11-M15 Group 4 M16-M20 Pool IV1 Pool III1 Negative Control Positive Control peptide stimulated peptide stimulate Data analysis The first round of screening Selection criteria The number of IFN-γ-secreting cells per one million PBMCs Three selection criteria The maximum the average The average per pig Statistical analysis Difference comparison compared (P < 0.05 ) Using SPSS 13.0 statistic software I 1 II 1 III 1 IV 1 V 1 VI 1 means Maximum 29 34 23 37 16 25 27.33 Average 11.33±1.91 16.07±2.60 12.8±1.82 8.27±2.37 8.47±0.95 15.53±1.87 12.08±0.85 NO.1 6.67±2.33 8.33±2.19 8±1.73 6.33±1.85 6.33±0.88 18.33±2.03 9±1.21 NO.2 15±4.62 15.33±0.33 18.67±0.88 23±7.02 11.33±2.60 17±2.08 16.72±1.54 NO.3 6.67±3.05 4.67±0.67 4±1.53 3±1 4±1.15 3.67±1.67 4.33±0.54 NO.4 19±5.13 24.67±4.41 18±3.61 5±1.73 9.67±1.45 23.33±1.20 16.61±2.06 NO.5 9.33±3.48 27.33±4.06 15.33±3.53 4±0.58 11±0.58 15.33±2.03 13.72±1.99 All the data are measured Result I:Four peptide pools I1, II1, III1,VI1 that generated values greater than or equal to the mean for the three selection criteria. Pool VI1 can elicit significantly higher IFN-γ secreting cells than pool IV1 and pools V1 (p<0.05). M1-M15 were selected to do the second round of ELISPOT assay. The second round of screening The last round of screening Selection criteria the number of IFN-γ-secreting cells per one million PBMCs I 2 II 2 III 2 IV 2 V 2 VI 2 VII 2 VIII 2 means Selection criteria the number of IFN-γ-secreting cells per one million PBMCs M2 M3 e M5 M6 e M8 e M8-v e M8-c e M9 M11 M12 e Mean Maximum 20 43 58 29 35 39 49 16 36.1 Average 9.27±1.6 21.6±3.5 34.67±3.7 17.4±1.7 20.8±2.8 20.8±2.5 29.33±3.3 9.6±1.4 20.43±1.2 NO.1 5±1.1 8.67±0.3 33.33±2.7 12±1.5 15±2.9 13±0.6 29.33±2.3 3.67±1.5 15±2.2 Maximum Average Response 31 170 48 198 261 147 128 25 87 171 126.6 12.1±2.7 77.9±19.6 14.1±5.2 92.7±21.1 88.6±29.8 68.1±14.2 66.9±12.7 11.3±2.5 44.1±8.0 75.7±16.4 55.15±5.6 NO.2 18.33±0.8 41.33±0.9 55.33±1.5 15.67±3.8 29±3.46 29.33±2.7 47±1.2 13.67±0.3 31.21±3.1 NO.3 0.33±0.3 12.67±0.7 17.33±1.2 12.33±1.5 4.67±0.9 11.33±0.9 13.33±0.9 3±1.2 9.38±1.2 NO.4 11±1.1 25.33±6.4 43.33±2.3 25.67±1.7 29±2.5 30.67±5.6 37.33±3.2 13.33±0.3 26.96±2.4 NO.5 11.67±0.9 20±8.1 24±1.7 21.33±1.5 26.33±2.7 19.67±4.3 19.67±1.2 14.33±0.9 19.63±1.4 Result II:Five peptide pools III2, IV2, V2, VI2, VII2 are comparatively stronger IFN-γ s than other peptide pools. Statistical analysis showed that the IFN-γ secreting cells stimulated by peptide pools III2, IV2, V2, VI2, VII2 are significantly higher than peptide pools I2 and VIII2. M2, M3, M5, M6, M8, M9, M11, M12 were selected to do the second round of ELISPOT assay. NO.1 10.5±3.5 24±6 6±3 38±3 31.5±6.5 29.5±9.5 34±6 8.5±0.5 29.5±9.5 44±4 25.55±3.14 NO.2 12.5±2.5 44.5±7.5 5±1 46±3 39±1 46±7 43.5±1.5 5.5±1.5 26±3 36±7 30.4±3.81 NO.3 7±0 164±6 44.5±3.5 194±4 259±2 143±4 109±19 14.5±3.5 86±1 152±19 117.3±17.7 6 NO.4 26±5 131.5±8.5 11.5±2.5 138.5±16.5 93±22 84.5±8.5 114±12 24±1 54.5±1.5 112.5±9.5 79±10.52 NO.5 4.5±1.5 25.5±2.5 3.5±1.5 47±1 20.5±1.5 37.5±0.5 34±1 4±1 24.5±2.5 34±6 23.5±3.39 Result III: Individual peptide M3, M6, M8, M12 can elicit high expression of IFN-g. Statistical analysis showed that the number of IFN-γ secreting cells stimulated by these four individual peptide was significantly higher than other peptides. 3

SFC/Million PBMCs Relative Ratio of IFN-γmRNA/CyPA mrna 02/08/2010 140 120 100 Further proven experiment TaqMan fluorescent quantitative Real-time PCR for detecting IFN-γ. 80 60 40 20 0 M2 M3 M5 M6 M8-H M8-V M8-C M9 M11 M12 The average of the eight candidate peptides M8-H----------High-pathgenic strain HuN4 M8-V----------Vaccine strain HuN4-F112 M8-C----------Representative strain Ch-1a 14 12 10 8 6 4 2 0 M3-1 M3-2 M3-3 M3-4 M3-5 M6-1 M6-2 M6-3 M6-4 M6-5 M8-1 M8-2 M8-3 M8-4 M8-5 M12-1 mock-stimulated cell cells stimulated by peptides Relative levels of IFN-γ mrna after the cells were stimulated by the four epitopes through Real-tine PCR. M12-2 M12-3 M12-4 M12-5 Conservation of identified M epitopes Multiple sequence alignment of the epitopes location between 42 American-type PRRSV strains 3. Conclusion Four T-cell epitopes presented in the matrix protein of HP-PRRSV were identified. 4. Acknowledgement The real-time PCR also showed that the cells stimulated by these four peptides can produce high quality of IFN-g, which proof our conclusion from another aspect. The result of the alignment demonstrated a great degree of identity at each site, MTEP6 was fully conserved ; MTEP3 and MTEP12 were conserved with only two amino acid changes; MTEP8 with 3 amino acid changes. 4

Acknowledgement Shanghai Veterinary Research Institute China Animal Health and Epidemiology Center (Shanghai) Department of Swine Infectious Diseases D r. Guang-Zhi Tong D r. Shi-Shan Yuan D r. Yan-Jun Zhou D r. Guo-Xin Li D r. Hai Yu D r. Shan-rui Zhang Yi-Feng Jiang, Ao-Tian Xu Li-Ping Yan, Meng-Meng Wang Y an-zhao Xu, Huan-Huan Liu Ji-Hong Ma, Jun-Wei Hou Wu Tong 5